Abstract 2099: Model-driven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice

Document type :
Conference papers
Complete list of metadatas

https://hal.inria.fr/hal-01404637
Contributor : Sebastien Benzekry <>
Submitted on : Tuesday, November 29, 2016 - 9:46:08 AM
Last modification on : Monday, May 13, 2019 - 2:58:51 PM

Identifiers

Collections

Citation

Joseph Ciccolini, Sebastien Benzekry, Sarah Giacometti, Fabrice Barlesi, Dominique Barbolosi. Abstract 2099: Model-driven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice. 107th Annual Meeting of the American Association for Cancer Research, 2016, New Orleans, France. pp.20, ⟨10.1158/1538-7445.AM2016-2099⟩. ⟨hal-01404637⟩

Share

Metrics

Record views

283